BeyondSpring
BYSI | NASDAQ
$0.58
-$0.02 (-3.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.58
$0.00 (-0.21%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-3.53%
(1D)No price chart data available for 1D timeframe.
Rating
26.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #887/1021 (Top 87%)
Key Statistics
Market Data
Market Cap $23.8M
1D Range
0.55 0.61
52W Range
0.43 2.35
Valuation (TTM)
PE -2.90
PB 1.56
EV/EBITDA -2.81
Valuation (NTM)
Forward PE 0.30
Forward PEG -0.04
Price Target $0.00
Cash Flow
FCF Yield -71.6%
SBC Adj. FCF Yield -71.6%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-63.3%
Dil EPS 3Y | 5Y 50.4% |
47.7%
FCF 3Y | 5Y -93.3% |
-17.6%
Returns
ROA -40.4%
ROE 36.9%
ROIC -56.3%
Financial Health
Net Cash
$501K
Current Ratio 0.28
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding...
Sector Healthcare
Industry Biotechnology
Employees 44
IPO Date Mar 9, 2017
Website www.beyondspringpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BYSI